Effect on rheumatoid factor and anti-Cyclic Citrullinated Peptide Antibodies Levels of treatment with Infliximab and Adalimumab in patients with Rheumatoid Arthritis

被引：0
|
作者：
Baos, Selene [1 ]
Plasencia, Chamaida [1 ]
Ramiro, Susana [1 ]
Moral, Rosario [1 ]
Diez, Jesus [1 ]
Martin-Mola, E. [1 ]
Balsa, Alejandro [1 ]
Pascual-Salcedo, Dora [1 ]
机构：
[1] La Paz Univ Hosp, Madrid, Spain
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1250
引用
收藏
页码：S489 / S489
页数：1
相关论文
共 50 条
  • [1] Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis
    De Rycke, L
    Verhelst, X
    Kruithof, E
    Van den Bosch, F
    Hoffman, IEA
    Veys, EM
    De Keyser, F
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 299 - 302
  • [2] Effect of infliximab therapy on anti-cyclic citrullinated peptide antibodies levels in patients with rheumatoid arthritis
    Kyriazis, NC
    Papalopoulou, M
    Balla, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 172 - +
  • [3] The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Chen, HA
    Lin, KC
    Chen, CH
    Liao, HT
    Wang, HP
    Chang, HN
    Tsai, CY
    Chou, CT
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (01) : 35 - 39
  • [4] Impact of treatment with infliximab on anti-cyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis.
    Mubashir, E
    Ahmed, MM
    Wolf, RE
    Hayat, S
    Hall, VC
    Shi, R
    Berney, SM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4098 - 4098
  • [5] Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis
    Kuru, Omer
    Bilgici, Ayhan
    Birinci, Asuman
    Ulusoy, Hasan
    Durupinar, Belma
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (10): : 650 - 654
  • [6] Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and comorbidity
    Stamenkovic, Doris
    Stiglic-Rogoznica, Nives
    Stiglic, Mirna
    Avancini-Dobrovic, Viviana
    Grubisic-Karavanic, Vlasta
    Frlan-Vrgoe, Ljubinka
    Radovic, Endi
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 707
  • [7] Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil
    Goeldner, Isabela
    Skare, Thelma L.
    Reason, Iara T. de Messias
    Nisihara, Renato M.
    Silva, Marilia B.
    da Rosa Utiyama, Shirley R.
    RHEUMATOLOGY, 2010, 49 (08) : 1590 - 1593
  • [8] Clinical Significance of Anti-Cyclic Citrullinated Peptide Antibodies and IgM Rheumatoid Factor in Rheumatoid Arthritis Patients
    Seo, Soyeon
    Lee, Jisoo
    Kang, Eun-Suk
    EWHA MEDICAL JOURNAL, 2005, 28 (02): : 87 - 92
  • [9] Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis
    Pinheiro, GC
    Scheinberg, MA
    da Silva, MA
    Maciel, S
    ANNALS OF INTERNAL MEDICINE, 2003, 139 (03) : 234 - 235
  • [10] Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis?
    Holers, V. Michael
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 400 - 401
12345